Clinical trial
Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
NCT00120406 is registered in ClinicalTrials.gov with Cook Group Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
- Lead sponsor
- Cook Group Incorporated
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- February 28, 2014
- Enrollment
- 474 (actual)
- Sites
- 52
Conditions
As the registry lists them; a condition with its own page is linked.